Innovent Announces Two Registration Studies of IBI306 (anti-

/PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high...

Related Keywords

China , Taiwan , United States , Peking , Beijing , Hong Kong , Macau , Suzhou , Jiangsu , Chinese , Innovent Biologics , Adimab Incyte , Yong Huo , Eli Lilly , China Cardiovascular Health , Md Anderson Cancer Center , University First Hospital , National Medical Products Administration , Incyte Corporation , Innovent Biologics Inc , Drug Evaluation , Peking University First Hospital , Lei Qian , Executive Director , Three Registration Clinical Studies , Total Cholesterol , Cardiovascular Health , Disease Report , Main Board , Stock Exchange , Hong Kong Limited , Cancer Center , Mainland China ,